Results of the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Hercules Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura - Scully, M; Cataland, S R; Peyvandi, F (Blood, 2017)
et al.